标题
Function of low ADARB1 expression in lung adenocarcinoma
作者
关键词
DNA methylation, Adenocarcinoma of the lung, Metastasis, Gene expression, Lung and intrathoracic tumors, Bioinformatics, Adenocarcinomas, Cancer treatment
出版物
PLoS One
Volume 14, Issue 9, Pages e0222298
出版商
Public Library of Science (PLoS)
发表日期
2019-09-07
DOI
10.1371/journal.pone.0222298
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma
- (2019) Yuanliang Yan et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap
- (2019) Jüri Reimand et al. Nature Protocols
- Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment
- (2019) Wanqing Chen et al. Lancet Global Health
- Roles of highly expressed PAICS in lung adenocarcinoma
- (2019) Shuyi Zhou et al. GENE
- The Secretion of miR-200s by a PKCζ/ADAR2 Signaling Axis Promotes Liver Metastasis in Colorectal Cancer
- (2018) Phillip M. Shelton et al. Cell Reports
- A myeloid differentiation factor 88 gene from yellow catfish Pelteobagrus fulvidraco and its molecular characterization in response to polyriboinosinic polyribocytidylic acid and lipopolysaccharide challenge
- (2018) Xiao-Ming Zhao et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications
- (2018) Hongmei Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Effect and Mechanism of Tanshinone I on the Radiosensitivity of Lung Cancer Cells
- (2018) Yuanliang Yan et al. MOLECULAR PHARMACEUTICS
- CCL2 is a vascular permeability factor inducing CCR2-dependent endothelial retraction during lung metastasis
- (2018) Marko Roblek et al. MOLECULAR CANCER RESEARCH
- RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA
- (2017) Aparna Anantharaman et al. FEBS LETTERS
- ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion
- (2017) Valeriana Cesarini et al. NUCLEIC ACIDS RESEARCH
- WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit
- (2017) Jing Wang et al. NUCLEIC ACIDS RESEARCH
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- RNA editing ofSLC22A3drives early tumor invasion and metastasis in familial esophageal cancer
- (2017) Li Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer
- (2016) Tim Hon Man Chan et al. GASTROENTEROLOGY
- ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma
- (2016) Yuan-Bin Chen et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- ADARB1 catalyzes circadian A-to-I editing and regulates RNA rhythm
- (2016) Hideki Terajima et al. NATURE GENETICS
- DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database
- (2016) Yichun Xiong et al. NUCLEIC ACIDS RESEARCH
- The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible
- (2016) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- KEGG: new perspectives on genomes, pathways, diseases and drugs
- (2016) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer
- (2016) Wen-Hsin Chang et al. PLoS One
- Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer
- (2015) Anna Díez-Villanueva et al. Epigenetics & Chromatin
- Abnormal expression of an ADAR2 alternative splicing variant in gliomas downregulates adenosine-to-inosine RNA editing
- (2014) Jun Wei et al. ACTA NEUROCHIRURGICA
- F-box protein complex FBXL19 regulates TGFβ1-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation
- (2014) Su Dong et al. Molecular Cancer
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression
- (2012) S. A. Selamat et al. GENOME RESEARCH
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Identification of Novel Deregulated RNA Metabolism-Related Genes in Non-Small Cell Lung Cancer
- (2012) Iñaki Valles et al. PLoS One
- Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors
- (2011) Amanda J Sales et al. BRITISH JOURNAL OF PHARMACOLOGY
- Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas
- (2011) H. Okayama et al. CANCER RESEARCH
- Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
- (2010) Jun Hou et al. PLoS One
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Reannotation of array probes at NCBI's GEO database
- (2008) Tanya Barrett et al. NATURE METHODS
- Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival
- (2008) Maria Teresa Landi et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started